(JREG) JPMorgan s (Ireland) ICAV - Ratings and Ratios
Global Stocks, Equity Funds, Index Tracking, Diversified Portfolio, Large Cap Stocks
Description: JREG JPMorgan s (Ireland) ICAV
The JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (acc) CHF is an actively managed ETF that seeks to outperform its benchmark, the Morningstar Global TME NR USD index, by investing in a globally diversified portfolio of companies. The funds objective is to achieve long-term returns in excess of the benchmark.
With an Assets Under Management (AUM) of $4.648 billion, this ETF is a sizable player in the Global Large-Cap Blend Equity category. To evaluate its performance, we can look at key metrics such as tracking error, information ratio, and Sharpe ratio, which are not provided in the given data. However, we can infer that the funds active management strategy is designed to generate alpha through stock selection and portfolio optimization.
From a technical analysis perspective, the ETFs price action can be assessed using various indicators. Although the current price is at its 52-week low, the ATR (Average True Range) of 0.73 (1.68%) suggests relatively moderate volatility. To further analyze the ETFs performance, we can examine its correlation with the benchmark, as well as its sector and geographic allocations, to identify potential sources of outperformance or underperformance.
To make informed investment decisions, its essential to monitor the ETFs performance against its benchmark and peers, using metrics such as returns, volatility, and risk-adjusted returns. A thorough analysis of the funds holdings, sector weights, and geographic exposures can also provide insights into its potential strengths and weaknesses.
Additional Sources for JREG ETF
JREG ETF Overview
Market Cap in USD | 4,648m |
Category | Global Large-Cap Blend Equity |
IPO / Inception | 2018-10-10 |
JREG ETF Ratings
Growth Rating | 59.2 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -22.1 |
Analysts | - |
Fair Price Momentum | 40.58 USD |
Fair Price DCF | - |
JREG Dividends
Currently no dividends paidJREG Growth Ratios
Growth Correlation 3m | 84.3% |
Growth Correlation 12m | 70.3% |
Growth Correlation 5y | 90% |
CAGR 5y | 22.23% |
CAGR/Max DD 5y | 0.92 |
Sharpe Ratio 12m | 1.20 |
Alpha | -10.91 |
Beta | 0.595 |
Volatility | 17.25% |
Current Volume | 0k |
Average Volume 20d | 0.6k |
As of July 03, 2025, the stock is trading at USD 43.48 with a total of 0 shares traded.
Over the past week, the price has changed by -19.27%, over one month by -16.67%, over three months by -12.05% and over the past year by -10.23%.
Partly, yes. Based on ValueRay´s Analyses, JPMorgan s (Ireland) ICAV (SW:JREG) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.19 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JREG is around 40.58 USD . This means that JREG is currently overvalued and has a potential downside of -6.67%.
JPMorgan s (Ireland) ICAV has no consensus analysts rating.
According to our own proprietary Forecast Model, JREG JPMorgan s (Ireland) ICAV will be worth about 45.9 in July 2026. The stock is currently trading at 43.48. This means that the stock has a potential upside of +5.54%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 45.9 | 5.5% |